Literature DB >> 19884247

Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology.

B Martin-Castillo, J Dorca, A Vazquez-Martin, C Oliveras-Ferraros, E Lopez-Bonet, M Garcia, S Del Barco, J A Menendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19884247     DOI： 10.1093/annonc/mdp494

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  26 in total

1.  Primary trastuzumab resistance: new tricks for an old drug.

Authors:  Jason A Wilken; Nita J Maihle
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

2.  Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Authors:  Xi Gu; Shi Jia; Wei Wei; Wen-Hai Zhang
Journal:  Tumour Biol       Date:  2015-02-15

Review 3.  Metformin: a therapeutic opportunity in breast cancer.

Authors:  Ana M Gonzalez-Angulo; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

4.  Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.

Authors:  Alejandro Vazquez-Martin; Eugeni López-Bonetc; Sílvia Cufí; Cristina Oliveras-Ferraros; Sonia Del Barco; Begoña Martin-Castillo; Javier A Menendez
Journal:  Drug Resist Updat       Date:  2011-05-19       Impact factor: 18.500

Review 5.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

6.  Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.

Authors:  Aleksei Viktorovich Novik; Svetlana Anatolievna Protsenko; Irina Alexandrovna Baldueva; Lev Michailovich Berstein; Vladimir Nikolaevich Anisimov; Irina Nikolaevna Zhuk; Anna Igorevna Semenova; Dilorom Khamidovna Latipova; Elena Viktorovna Tkachenko; Tatiana Yurievna Semiglazova
Journal:  Oncologist       Date:  2021-04-09

7.  Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

Authors:  Bin Bao; Zhiwei Wang; Shadan Ali; Aamir Ahmad; Asfar S Azmi; Sanila H Sarkar; Sanjeev Banerjee; Dejuan Kong; Yiwei Li; Shivam Thakur; Fazlul H Sarkar
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-15

8.  Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.

Authors:  Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Elisabet Cuyàs; Bruna Corominas-Faja; Esther Rodríguez-Gallego; Salvador Fernández-Arroyo; Begoña Martin-Castillo; Jorge Joven; Javier A Menendez
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

Review 9.  Diabetes and cancer: Associations, mechanisms, and implications for medical practice.

Authors:  Chun-Xiao Xu; Hong-Hong Zhu; Yi-Min Zhu
Journal:  World J Diabetes       Date:  2014-06-15

10.  Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system.

Authors:  Daniel R Budman; Anthony Calabro; Lisa Rosen; Martin Lesser
Journal:  Anticancer Drugs       Date:  2012-03       Impact factor: 2.248
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.